PMID- 11873624 OWN - NLM STAT- MEDLINE DCOM- 20020419 LR - 20191105 IS - 0369-8114 (Print) IS - 0369-8114 (Linking) VI - 50 IP - 1 DP - 2002 Feb TI - [Clinical and serological characteristics of systemic lupus erythematosus: 128 cases]. PG - 18-24 AB - OBJECTIVE: To analyse the clinical and serological characteristics of systemic lupus erythematosus (SLE) in the center of Tunisia. METHODS: We studied 128 patients with SLE aged one to 73 years. Antinuclear antibodies (ANA) were detected by an immunofluorescence method. Anti-double-stranded DNA (anti-dsDNA) antibodies, anti-extractable nuclear antigen antibodies (anti-Sm, anti-SS-A, anti-SS-B and anti-RNP) and anti-cardiolipin (aCL of IgG, IgA and IgM isotypes) antibodies were detected by ELISA. RESULTS: Malar rash (71%) and anemia (71%) were the most common clinical manifestations. Arthritis was seen in 62.5%. Severe kidney damage was observed in 39%. Pericarditis and pleuritis were observed in only 23%. Neurological manifestations (16%) were uncommon. Clinical manifestations of anti-phospholipid syndrome (SAPL) were observed in 15%. ANA were detected in 100%, anti-dsDNA in 76%, anti-Sm in 55.5%, anti-SS-A in 64%, anti-SS-B in 33.6%, anti-RNP in 49%. aCL of IgG, IgA and IgM isotypes were detected in 63.5%, 49% and 40.6% of the patients respectively. The only significant positive clinical associations were those of arthritis with anti-dsDNA antibodies (p = 0.022) and malar rash with anti-SS-A antibodies (p = 0.002). CONCLUSIONS: This study suggests that tunisians with SLE present, in general, a mild form of disease predominantly manifested by cutaneous, musculoskeletal and hematologic involvement but low prevalence of major organ damage. FAU - Ghedira, I AU - Ghedira I AD - Laboratoire de microbiologie-immunologie, CHU Farhat Hached, avenue Ibn El Jazzar, 4000, Sousse, Tunisie. Ibtissem.Ghedira@fphm.rnu.tn FAU - Sakly, W AU - Sakly W FAU - Jeddi, M AU - Jeddi M LA - fre PT - English Abstract PT - Journal Article TT - Caracteristiques cliniques et serologiques du lupus erythemateux systemique: a propos de 128 cas. PL - France TA - Pathol Biol (Paris) JT - Pathologie-biologie JID - 0265365 RN - 0 (Antibodies, Antinuclear) RN - 0 (Autoantibodies) RN - 0 (Immunoglobulin G) RN - 0 (Immunoglobulin M) SB - IM MH - Adult MH - Aged MH - Antibodies, Antinuclear/blood MH - Autoantibodies/blood MH - Female MH - Humans MH - Immunoglobulin G/blood MH - Immunoglobulin M/blood MH - Lupus Erythematosus, Systemic/blood/diagnosis/*immunology MH - Male MH - Middle Aged MH - Retrospective Studies EDAT- 2002/03/05 10:00 MHDA- 2002/04/20 10:01 CRDT- 2002/03/05 10:00 PHST- 2002/03/05 10:00 [pubmed] PHST- 2002/04/20 10:01 [medline] PHST- 2002/03/05 10:00 [entrez] AID - S0369-8114(01)00262-0 [pii] AID - 10.1016/s0369-8114(01)00262-0 [doi] PST - ppublish SO - Pathol Biol (Paris). 2002 Feb;50(1):18-24. doi: 10.1016/s0369-8114(01)00262-0.